These IHC data showed that EZH2 is more highly expressed and LATS1 is more lowly expressed in human RCC tissues than healthy tissues (NT/T: 1.7/25.9 for EZH2 and 10.3/2.2 for LATS1) (Fig. 5A,B). This evidence concerns the gene LATS1 and renal cell carcinoma.